Publication: Hypertrophic scar outcomes in fractional laser monotherapy versus fractional laser-assisted topical corticosteroid delivery: A randomized clinical trial
2
Issued Date
2021-01-01
Resource Type
ISSN
16512057
00015555
00015555
Other identifier(s)
2-s2.0-85103096795
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Acta Dermato-Venereologica. Vol.101, No.3 (2021)
Suggested Citation
Woraphong Manuskiatti, Arisa Kaewkes, Chadakan Yan, Janice Natasha Ng, Joshua Zev Glahn, Rungsima Wanitphakdeedecha Hypertrophic scar outcomes in fractional laser monotherapy versus fractional laser-assisted topical corticosteroid delivery: A randomized clinical trial. Acta Dermato-Venereologica. Vol.101, No.3 (2021). doi:10.2340/00015555-3781 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78786
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Hypertrophic scar outcomes in fractional laser monotherapy versus fractional laser-assisted topical corticosteroid delivery: A randomized clinical trial
Other Contributor(s)
Abstract
Topical corticosteroid delivery following fractional laser treatment is an effective means of treating hypertrophic scars. However, the relative efficacy of adjuvant corticosteroid treatment vs fractional laser monotherapy alone is unclear. The aim of this study was to compare the efficacy and safety of fractional laser-assisted topical corticosteroid delivery with fractional laser monotherapy in the treatment of hypertrophic scars. In this randomized, comparative, split-scar trial of 19 subjects, a borderline significant reduction in scar thickness was observed at 3-month follow-up in the laser+steroid group compared with laser+petrolatum (p = 0.049). However, no significant long-term difference in scar flattening was observed between the 2 groups. Patient and Observer Scar Assessment Scale scores showed significant improvement in scar appearance from baseline without significant differences between treatment groups. In conclusion, fractional laser monotherapy is an effective treatment for hypertrophic scars, and the application of topical corticosteroid provides no long-term synergistic effect to fractional laser monotherapy.